We invest in ideas and commercialise results
We take commercially promising research and build companies that enterprise and innovate, creating positive societal, economic and environmental change.
We offer a combination of expertise, skills and facilities to help our spinouts succeed, and connect companies with funding networks and guide them in protecting and enhancing intellectual property.
Professor Andrew Hopkins, Chief Executive, Exscientia
Moray Martin, Tricapital chief executive
Read about some of our success stories...
Developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.
DC Biosciences Ltd
DC Biosciences Ltd provides pharmaceutical and biotech companies with proteomics services to accelerate the development of safer drugs.
Glencoe Software Ltd
Design and production of software and data storage solutions for biological imaging. Glencoe Software is the commercial arm of the Open Microscopy Environment, a community-led, open source data specification and software development consortium.
Specialises in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including eczema, non-melanoma skin cancers and orphan skin diseases.
Developing powerful new software solutions for managing complex informatics and multidimensional proteomics scientific datasets in a wide range of laboratory and industrial environments.